Forty Seven fetches $75 mln Series B
Menlo Park, California-based Forty Seven Inc, a developer of next-generation immuno-oncology treatments, has closed $75 million in Series B financing. Wellington Management Company LLP led the round with participation from return backers Clarus, Lightspeed Venture Partners, Sutter Hill Ventures and GV.
19 October 2017•1 min read
